ARTICLE | Clinical News
Bind Therapeutics, AstraZeneca preclinical data
July 13, 2015 7:00 AM UTC
In mouse xenograft models of small cell lung cancer (SCLC) and diffuse large B cell lymphoma (DLBCL), AZD2811 inhibited tumor growth and led to tumor regression. Data were presented at the American A...